Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Beyond cost arbitrage: globally networked polycentric r&d addressing affordability and accessibility

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: BARBHAIYA, Rashmi (Advinus Therapeutics Ltd, Bangalore, India)
  • Abstract:

    The introduction of the first-in-class ACE inhibitor Captopril was a phenomenal success story from a large pharma - the concept of ACE inhibition for the treatment of hypertension, identification & development of a safe & effective molecule, its manufacturing and sales/marketing was done by one company. Over the past four decades since this..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses